When: Price breaks above $363 on volume >7M with MACD bullish re-cross before any drawdown

Then: Re-evaluate toward Overweight after tail hedge execution per 8/14 rule

When: Price closes below $347.55 on volume (8/21 elevated bar met)

Then: Re-evaluate toward Underweight

HOLD current weight; do not add without technical confirmation (specifically, 50 SMA reclaim with MACD positive turn); use any relief rally into $362-366 to trim toward neutral; wait for tape to confirm before deploying additional capital.

• 200 SMA at $317.78 represents hard technical support level; breach on volume targets $277-279 range (approximately 21% drawdown), not 9%
• Q1 2026 EPS was only $5.94; 47% YoY earnings growth includes $4.39 billion special charge distorting comparisons
• NII Q2 at $25.5 billion: interest expense grew 5.4% sequentially while interest income grew only 2.9%, showing deteriorating spread dynamics
• Forward EPS consensus is $24.99; Q3 earnings in mid-October present known catalyst risk for disappointment on credit costs, NIM guidance, or deposit beta
• Shareholder yield is 5.2%; high-quality franchise will be intact regardless of near-term volatility
• JPM beta is 0.975; stock moves with market and cannot decouple from equity multiple compression if 10-year sustains above 5%
• Stock sits below three moving averages (10 EMA, 50 SMA, VWMA) with RSI at 44 and bearish MACD cross

→ vs aggressive: The '9% downside requires multiple things to break' argument is dangerous framing—tail events by definition involve everything breaking at once (2023 regional banks, 2008 GFC, 2018 Q4 all saw simultaneous deterioration across deposits, NII, and capital return)

→ vs aggressive: Base-rate reasoning on a single bullish scenario ignores the fat tail; the 200 SMA is a hard technical level where institutional support historically kicks in, not a probability-weighted number

→ vs aggressive: 47% YoY growth figure is distorted by $4.39 billion special charge; Q1 2026 EPS of only $5.94 shows trajectory is not as clean as headline suggests

→ vs aggressive: Paying 1.5-3% more for confirmation is not underperformance—it is the cost of insurance against false breakdown in a stock with bearish MACD cross, below three moving averages, and RSI at 44

→ vs aggressive: Higher-for-longer is bullish for NII but bearish for equity multiples, credit costs, and broader risk environment; JPM cannot decouple from market given 0.975 beta

→ vs aggressive: Q2 NII reflects trailing benefit of steep curve and loan growth; does not reflect forward compression risk as deposit costs catch up, particularly if Fed hikes

→ vs aggressive: FOMC 3-out-of-4 bullish outcomes framing is not how probability works; event risk is always two-tailed, and hawkish communication could be as damaging as 50bp surprise

→ vs aggressive: Fee income is cyclical—capital markets revenue cuts in half in down years, AWM fee compression on AUM decline; structural luxury card competition threat at high end unquantified

→ vs aggressive: JPM strategy desk 'don't chase sell-off' is marketing message to retain client engagement, not analytical signal; sell-side desks say this every market wobble

→ vs aggressive: HOLD is not 'do nothing forever'—it is a position with specific re-rating triggers (50 SMA reclaim with MACD positive turn, defended pullback to lower Bollinger at $349.33 with bullish reversal candle) designed to fire within days; cost of waiting is functionally zero in a $30 range chop

HOLD current weight; establish partial add at current levels with $347.55 stop sized at one-third to one-half of intended full add; reserve remaining add capacity for post-FOMC confirmation (defended FOMC-day low with bullish reversal OR breakout above $354.90 with volume); trim zone at $362-366 on relief rally

• 200 SMA support argument is circular reasoning—saying support won't break because it requires itself to break; actual question is probability of 5-9% drawdown given bearish momentum indicators
• Base case scenario (15-20% probability) of testing lower Bollinger Band at $349 requires only hawkish Fed surprise and bond yield surge, not credit cycle breakdown
• Fundamentals provide valuation floor: P/B of 2.63x, 17.79% ROE, 5.2% shareholder yield (3.5% buyback + 1.7% dividend)
• Q2 NII of $25.5B up 9.9% YoY is real but rate of growth decelerating—interest expense up 5.4% sequentially vs. interest income up only 2.9%
• AWM revenue more durable than capital markets; $1.1 billion fund close is structural signal; Kioxia IPO fees not P&L until deal closes
• 14x forward P/E vulnerable to compression if 10-year yields stay above 5% and equity risk premium expands 50 bps
• Q2 earnings print already in price at $352; market pricing FOMC and curve path, not next earnings
• Asymmetric risk: upside to $362 is $12, downside to $317 is $32 at current levels
• Lower Bollinger Band at $349.33 is partial mean-reversion signal for partial add
• Post-FOMC triggers more actionable than stacked 50 SMA reclaim AND MACD turn

→ vs aggressive: Circular reasoning on 200 SMA—arguing support won't fail because it requires support to fail ignores that every support level requires multiple breaks to fail

→ vs aggressive: Base case scenario of testing $349 has 15-20% probability; aggressive analyst treating it like 2% tail risk

→ vs aggressive: 'Confirmation from fundamentals, not price' framing is operationally dangerous—fundamentals don't protect from gap down on hawkish Fed surprise

→ vs aggressive: Three-out-of-four bullish scenario tree is mathematically suspect; event risk genuinely two-tailed

→ vs aggressive: Q2 earnings already in price at $352; aggressive analyst overestimating earnings catalyst

→ vs conservative: Treating every technical weakness as precursor to regime change is mirror-image mistake to aggressive analyst

→ vs conservative: Fat-tail argument and 'fundamentals irrelevant until price confirms' is building tactical framework around 5% scenarios—will never deploy capital

→ vs conservative: JPM in 2024 is fundamentally different from 2008/2018 with 17.79% ROE, 1.36% ROA, $5T assets, CET1 above 14%—conservative analyst not adjusting for JPM's demonstrated resilience

→ vs conservative: Q3 earnings concerns are premature—don't make tactical decisions today on hypothetical earnings outcomes not telegraphed by company; this is paralysis not risk management

→ vs conservative: HOLD as 'do nothing' framing is incorrect—partial add at current levels is an active tactical position